Clinical Trials Browser

Leukemia, Lymphoma, Multiple Myeloma, Pulmonary Embolism, Hematologic Neoplasms, Venous Thromboembolism

NCT02066454 2025-08-13

MYELAXAT

Phase 3 Completed

108 enrolled

Classical hematologyPlasma cell

Neoplasms, Plasma Cell, Venous Thromboembolism

NCT06580223 2025-07-18

Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma

Phase 3 Not yet recruiting

530 enrolled

Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

NCT05541978 2023-07-03

THRIMM

Completed

140 enrolled

Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

NCT03405571 2021-04-28

ROADMAP-MM

Unknown

800 enrolled

Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

NCT04106700 2021-02-15

Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs

Phase 2 Terminated

60 enrolled

Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

NCT02958969 2019-12-17

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma

Phase 4 Completed

50 enrolled 5 charts

Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

NCT01855698 2018-03-22

PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism

Completed

99 enrolled

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Hematologic Neoplasms, Venous Thromboembolism

Clinical Trials

HEM-DOAC

MYELAXAT

Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma

THRIMM

ROADMAP-MM

Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma

PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism